{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AC-1204", "query": { "intervention": "AC-1204" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T21:38:55.912Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02959710", "title": "Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "AC-1204 mixed in water", "type": "DRUG" }, { "name": "AC-1202 mixed in water", "type": "DRUG" }, { "name": "AC-1202 mixed in Ensure®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 16, "start_date": "2016-11", "completion_date": "2017-04", "has_results": false, "last_update_posted_date": "2017-04-11", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02959710" }, { "nct_id": "NCT02716662", "title": "Safety of Caprylic Triglycerides in ALS: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "ALS" ], "interventions": [ { "name": "Axona", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 10, "start_date": "2016-01-01", "completion_date": "2018-04-25", "has_results": false, "last_update_posted_date": "2018-04-27", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02716662" }, { "nct_id": "NCT02833012", "title": "Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Caprylic Triglyceride Oil", "type": "DRUG" }, { "name": "AC-1202", "type": "DRUG" }, { "name": "Axona", "type": "DRUG" }, { "name": "AC-1204", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 20, "start_date": "2016-07", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2017-04-11", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02833012" }, { "nct_id": "NCT01211782", "title": "AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "caprylic triglyceride", "type": "DRUG" }, { "name": "long-chain triglyceride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 0, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2012-12-04", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 1, "location_summary": "St. Petersburg, Florida", "locations": [ { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01211782" }, { "nct_id": "NCT02747602", "title": "Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "AC-1204", "type": "DRUG" }, { "name": "caprylic triglyceride oil (standard breakfast)", "type": "DRUG" }, { "name": "caprylic triglyceride oil (high fat breakfast)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 16, "start_date": "2016-04", "completion_date": "2016-10", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02747602" }, { "nct_id": "NCT01741194", "title": "AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "AC-1204", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "66 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "66 Years to 90 Years" }, "enrollment_count": 418, "start_date": "2013-03", "completion_date": "2017-04-14", "has_results": false, "last_update_posted_date": "2021-08-02", "last_synced_at": "2026-09-03T21:38:55.912Z", "location_count": 82, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Hot Springs, Arkansas + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01741194" } ] }